Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma.
Nicolas
N
André
Arnauld
A
Verschuur
Angélique
A
Rome
Carole
C
Coze
Jean-Claude
JC
Gentet
Laetitia
L
Padovani
D000293:Adolescent; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy*
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine